134 related articles for article (PubMed ID: 35749760)
21. Hepatocellular adenomas in a large community population, 2000 to 2010: reclassification per current World Health Organization classification and results of long-term follow-up.
Shafizadeh N; Genrich G; Ferrell L; Kakar S
Hum Pathol; 2014 May; 45(5):976-83. PubMed ID: 24746201
[TBL] [Abstract][Full Text] [Related]
22. Focal nodular hyperplasia of the liver in children: A report of 2 cases.
Islam N; Halder A; Ghosh R; Banerjee S; Mishra PK; Chatterjee U
Indian J Pathol Microbiol; 2019; 62(2):261-265. PubMed ID: 30971551
[TBL] [Abstract][Full Text] [Related]
23. Glypican-3 as a useful diagnostic marker that distinguishes hepatocellular carcinoma from benign hepatocellular mass lesions.
Wang HL; Anatelli F; Zhai QJ; Adley B; Chuang ST; Yang XJ
Arch Pathol Lab Med; 2008 Nov; 132(11):1723-8. PubMed ID: 18976006
[TBL] [Abstract][Full Text] [Related]
24. [Interest of immunohistochemistry for the diagnosis of benign hepatocellular tumors].
Bioulac-Sage P; Balabaud C; Zucman-Rossi J
Ann Pathol; 2010 Dec; 30(6):439-47. PubMed ID: 21167430
[TBL] [Abstract][Full Text] [Related]
25. Distinction of hepatocellular carcinoma from benign hepatic mimickers using Glypican-3 and CD34 immunohistochemistry.
Coston WM; Loera S; Lau SK; Ishizawa S; Jiang Z; Wu CL; Yen Y; Weiss LM; Chu PG
Am J Surg Pathol; 2008 Mar; 32(3):433-44. PubMed ID: 18300806
[TBL] [Abstract][Full Text] [Related]
26. Severe cytological atypia (large cell change) in focal nodular hyperplasia with numerous mallory bodies. A benign (adaptive) change?
Agaimy A; Kaiser A; Wuensch PH
Pathol Res Pract; 2003; 199(7):509-11. PubMed ID: 14521270
[TBL] [Abstract][Full Text] [Related]
27. Focal Nodular Hyperplasia in the Pediatric Population: A Multicenter Experience.
González IA; Wang D; Pacheco MC; Zhang X; Russo P
Pediatr Dev Pathol; 2023; 26(4):352-361. PubMed ID: 37082924
[TBL] [Abstract][Full Text] [Related]
28. Parametric imaging with contrast-enhanced ultrasound: usefulness for characterization of dynamic effects of microvascularization for hepatocellular carcinoma and focal nodular hyperplasia.
Zheng SG; Xu HX; Liu LN; Wang Y; Zhang YF; Guo LH; Liu C; Xu JM; Sun LP; Wu J
Clin Hemorheol Microcirc; 2013; 55(3):375-89. PubMed ID: 23271200
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
[TBL] [Abstract][Full Text] [Related]
30. [Study on the morphological features, pathologic diagnosis and differential diagnosis of well-differentiated hepatocellular carcinoma].
Wei L; Du J; Wang Y; Shi H; Zhao J
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):459-62. PubMed ID: 25327795
[TBL] [Abstract][Full Text] [Related]
31. Use of 64-Slice Spiral CT Examinations for Hepatocellular Carcinoma (DR LU).
Chen X; Yang Z; Deng J
J BUON; 2019; 24(4):1435-1440. PubMed ID: 31646788
[TBL] [Abstract][Full Text] [Related]
32. [Clinical features of surgically resected focal nodular hyperplasia of the liver].
Hwang NC; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Rhee JC; Lee KW; Joh JW; Park CK
Korean J Hepatol; 2004 Jun; 10(2):135-41. PubMed ID: 15218347
[TBL] [Abstract][Full Text] [Related]
33. Hepatocellular carcinoma with a central scar and a scalloped tumor margin resembling focal nodular hyperplasia in macroscopic appearance.
Yamamoto M; Ariizumi S; Yoshitoshi K; Saito A; Nakano M; Takasaki K
J Surg Oncol; 2006 Dec; 94(7):587-91. PubMed ID: 17066420
[TBL] [Abstract][Full Text] [Related]
34. MicroRNA Expression in Focal Nodular Hyperplasia in Comparison with Cirrhosis and Hepatocellular Carcinoma.
Lendvai G; Szekerczés T; Gyöngyösi B; Schlachter K; Kontsek E; Pesti A; Patonai A; Werling K; Kovalszky I; Schaff Z; Kiss A
Pathol Oncol Res; 2019 Jul; 25(3):1103-1109. PubMed ID: 30411298
[TBL] [Abstract][Full Text] [Related]
35. Focal nodular hyperplasia: findings at state-of-the-art MR imaging, US, CT, and pathologic analysis.
Hussain SM; Terkivatan T; Zondervan PE; Lanjouw E; de Rave S; Ijzermans JN; de Man RA
Radiographics; 2004; 24(1):3-17; discussion 18-9. PubMed ID: 14730031
[TBL] [Abstract][Full Text] [Related]
36. Focal nodular hyperplasia-like nodule with reduced expression of organic anion transporter 1B3 in alcoholic liver cirrhosis.
Doi N; Tomiyama Y; Kawase T; Nishina S; Yoshioka N; Hara Y; Yoshida K; Korenaga K; Korenaga M; Moriya T; Urakami A; Nakashima O; Kojiro M; Hino K
Intern Med; 2011; 50(11):1193-9. PubMed ID: 21628934
[TBL] [Abstract][Full Text] [Related]
37. Differentiation Between Hepatocellular Carcinoma Showing Hyperintensity on the Hepatobiliary Phase of Gadoxetic Acid-Enhanced MRI and Focal Nodular Hyperplasia by CT and MRI.
Kitao A; Matsui O; Yoneda N; Kita R; Kozaka K; Kobayashi S; Gabata T
AJR Am J Roentgenol; 2018 Aug; 211(2):347-357. PubMed ID: 29708786
[TBL] [Abstract][Full Text] [Related]
38. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
[TBL] [Abstract][Full Text] [Related]
39. Hepatocellular adenoma and focal nodular hyperplasia: a series of 24 patients with clinicopathological and radiological correlation.
Ji Y; Zhu X; Sun H; Tan Y; Ma Z; Ye Q; Sujie A; Tang Z
Chin Med J (Engl); 2000 Sep; 113(9):852-7. PubMed ID: 11776086
[TBL] [Abstract][Full Text] [Related]
40. Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?
Rafaelian O; Coakley FV; Qayyum A; Breiman RS; Yeh BM; Joe BN; Westphalen AC; Feng S
J Comput Assist Tomogr; 2006; 30(5):796-9. PubMed ID: 16954932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]